NYSE:IWM Fund Quote
200.45
-4.16 (-2.03%)
iShares Russell 2000 ETF is a security that trades on the New York Stock Exchange
The Finchat-compiled consensus estimates call for adjusted earnings per share (EPS) of $1.06 and revenue of $235.64 million for the first quarter of the fiscal year 2025.
Via Stocktwits · March 31, 2025

With last week's move to the downside we now have to consider new swing lows for indices, with the ones established a couple of weeks ago unlikely to hold.
Via Talk Markets · March 30, 2025
Continued downside is expected as the markets continue to move through the
Via Talk Markets · March 30, 2025
After 3 weeks of staying net long, hedge funds once again switched back to net short e-mini S&P500 futures.
Via Talk Markets · March 30, 2025
The positives are elusive. The breadth indicators show the possibility of a serious decline in prices in the near future. But at least the bottom for this decline should be easy to identify by a sharp decrease in the number of new lows.
Via Talk Markets · March 29, 2025
Analyzing the recent market correction as key technical levels break down.
Via Talk Markets · March 29, 2025
In this week's video, we'll review the latest charts and data to help us understand the good, the bad, and the ugly in the stock market.
Via Talk Markets · March 29, 2025
Markets faltered on Friday, with Wall Street reeling as investors hurried to shed risk in the face of mounting inflation and tariff uncertainties.
Via Benzinga · March 28, 2025
Fourth-quarter loss per share came in at $0.16, lower than the $0.24 in the corresponding period of 2023, and below the consensus estimate of $0.25, according to FinChat data.
Via Stocktwits · March 28, 2025
Are we heading toward a recession?
Via The Motley Fool · March 28, 2025
Morgan Stanley expects the core monthly PCE rate to be 0.35%, rounding off to 0.4%, nudged higher by strong goods inflation and an acceleration in core services prices, excluding housing.
Via Stocktwits · March 28, 2025
The 24Q4 Y/Y blended earnings growth estimate is 45.8%. If the energy sector is excluded, the growth rate for the index is 75.0%.
Via Talk Markets · March 27, 2025
Wall Street dipped slightly on Thursday, with all major indexes edging into the red as investors digested President Donald Trump‘s latest move on auto tariffs.
Via Benzinga · March 27, 2025
The study included 46 fully treated patients, with 37% of those with progressive disease still alive after two years.
Via Stocktwits · March 27, 2025
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Wednesday, March 26.
Via Talk Markets · March 26, 2025
Verint noted that ASC 606, a set of accounting rules governing how a company recognizes revenue from customer contracts, impacted its top- and bottom-line results.
Via Stocktwits · March 26, 2025

The S&P had the picture-perfect reversal off resistance, undercutting its 200-day MA in the process.
Via Talk Markets · March 26, 2025
At the Investor Day held in mid-January, the company said it has transitioned to a subscription model, with 80% of the revenue for the year coming from subscription offerings.
Via Stocktwits · March 26, 2025
U.S. stocks decline on renewed tariff concerns, technology shares lead selloff while blue-chip stocks are more resilient. VIX jumps 8%, dollar and Treasury yields remain flat.
Via Benzinga · March 26, 2025
Recent market volatility is a function of President Donald Trump’s tariff talks and the uncertainty surrounding monetary policy.
Via Stocktwits · March 26, 2025
Raymond James said the adverse reaction of Lumen stock is due to the deal value being lower than the $6 billion to $9 billion stated by a Reuters report in December.
Via Stocktwits · March 26, 2025
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Tuesday, March 25.
Via Talk Markets · March 25, 2025
The drug showed no treatment benefit for patients in the study called REFOCUS-ALZ, the company said, while adding that the Alzheimer’s disease development program with Simufilam will be discontinued by the end of the second quarter of 2025.
Via Stocktwits · March 25, 2025
Wall Street’s recovery from its recent technical correction paused for a breather on Tuesday, as investors awaited more clarity on tariff developments and digested a downbeat consumer confidence report.
Via Benzinga · March 25, 2025
The company reported earnings of $0.22 per share compared with a loss of $0.26 per share in the corresponding period of 2023, owing to the launch of its lead product, DefenCath.
Via Stocktwits · March 25, 2025